IPP Bureau
Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
By IPP Bureau - April 07, 2026
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
By IPP Bureau - April 07, 2026
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Fischer Medical converts warrants into equity, infuses Rs 10.53 crore
By IPP Bureau - April 07, 2026
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
By IPP Bureau - April 06, 2026
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute
By IPP Bureau - April 06, 2026
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer
By IPP Bureau - April 06, 2026
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access
By IPP Bureau - April 06, 2026
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS
By IPP Bureau - April 06, 2026
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Samsung Biologics lands first US manufacturing facility with GSK acquisition
By IPP Bureau - April 06, 2026
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
By IPP Bureau - April 06, 2026
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Enveric Biosciences bags key US patent for mental health drug
By IPP Bureau - April 06, 2026
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
By IPP Bureau - April 06, 2026
Move aligns global biologics identity under the Biocon Biologics brand
Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
By IPP Bureau - April 06, 2026
Safety was equally impressive. ENV-294 was well tolerated
AIIMS New Delhi partners with MediSim VR to advance VR skill training in medical education
By IPP Bureau - April 06, 2026
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
By IPP Bureau - April 06, 2026
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
